Oscar Health, Inc.

Fundamentals7.0
Price Action4.0
News Sentiment6.0
AI Rating
6.0

Key Drivers

  • Strong free cashflow
  • Negative operating margins
  • Net cash position

AI
AI Summary

6.0

Oscar is no longer a pure growth-at-all-costs story but a near-term "prove-it" recovery: the investment hinges on whether pricing, narrow-network actions and AI-driven SG&A cuts can compress rolling MLR by several hundred basis points and convert strong free cash flow into durable underwriting profits by 2026. Monitor weekly rolling MLR, enrollment-weighted premium growth, and SG&A% for clear evidence—failure to show sustained MLR compression or risk-adjustment stability creates material downside despite the cash runway.

CashGeneration
MLRRisk
ProveIt‍

Price Chart

Loading chart...

Financial Metrics

-
Revenue (TTM)
-
Net Income (TTM)
-
EPS (Q)
-
MCAP

Deep Analysis

Research tool. Not personalized advice.

Fundamental Analysis

7.0

Key Financial Insights:

  • Strong free cashflow
  • Negative operating margins
  • Net cash position

Oscar Health combines substantial cash and strong free cash flow with persistent operating and quarterly margin losses and short-term liquidity strain, making cost control and margin recovery the priority.

CashStrength
MarginRisk

Price Behavior

4.0
Research tool. Not personalized advice. Technical analysis is for informational purposes only.

Key Price Behavior Insights:

  • Below last month
  • Near $12.30 support
  • Resistance cluster $13.6–$15.0

OSCR is in a short-term downtrend—trading below its last month average and down from recent highs, testing support near $12.30 with resistance around $13.6–$15.0 that must clear to resume an uptrend.

bearish
watch
Support Level: $12.30
Resistance Level: $13.60–$15.00

~20% swing from $15.05 to $12.30 over the period indicates elevated short-term volatility

Sentiment & News

6.0

Key News Insights:

  • 21.7% pullback
  • 50-day breakout
  • Mixed analyst sentiment

Oscar Health shares plunged ~21.7% from late Jan to Feb but have shown a short-term technical rebound above the 50-day MA while management reiterates a 2026 profit target amid mixed analyst and institutional signals.

ProfitTarget
Volatility

The combination of a steep recent decline, a technical bounce and reiterated profitability guidance makes OSCR a near-term momentum/watchlist candidate, but mixed coverage and institutional moves keep longer-term conviction cautious